Cerebrovascular diseases are caused by interruption or significant impairment of the blood supply to the brain, which leads to a cascade of metabolic and molecular alterations resulting in functional disturbance and morphological damage. These pathophysiological changes can be assessed by positron emission tomography (PET), which permits the regional measurement of physiological parameters and imaging of the distribution of molecular markers. PET has broadened our understanding of the fl ow and metabolic thresholds critical for the maintenance of brain function and morphology: in this application, PET has been essential in the transfer of the concept of the penumbra (tissue with perfusion below the functional threshold but above the threshold for the preservation of morphology) to clinical stroke and thereby has had great impact on developing treatment strategies. Radioligands for receptors can be used as early markers of irreversible neuronal damage and thereby can predict the size of the fi nal infarcts; this is also important for decisions concerning invasive therapy in large ("malignant") infarctions. With PET investigations, the reserve capacity of blood supply to the brain can be tested in obstructive arteriosclerosis of the supplying arteries, and this again is essential for planning interventions. The effect of a stroke on the surrounding and contralateral primarily unaffected tissue can be investigated, and these results help to understand the symptoms caused by disturbances in functional networks. Chronic cerebrovascular disease causes vascular cognitive disorders, including vascular dementia. PET permits the detection of the metabolic disturbances responsible for cognitive impairment and dementia, and can differentiate vascular dementia from degenerative diseases. It may also help to understand the importance of neuroinfl ammation after stroke and its interaction with amyloid deposition in the development of dementia. Although the clinical application of PET investigations is limited, this technology had and still has a great impact on research into cerebrovascular diseases.
Introduction
The burden of cerebrovascular disease (CVD) is extremely high: in 2000 there were 15.3 million strokes world-wide, 5.5 million of which resulted in death [1] . But CVD accounts not only for 10% of all deaths; it is also the leading cause of disability in patients surviving the insult [2] . However, there exists a high variation in stroke burden and mortality, with >85% of strokes occurring in low-and middle-income countries [3] . In addition, CVD not only causes strokes, but is also associated with a high incidence of silent infarcts and microhemorrhages that lead to cognitive and behavioral changes, finally presenting as vascular dementia or cognitive impairment. Eight percent of the US population aged over 65 years experience a stroke, 8% suffer from dementia, and 17% from mild cognitive impairment of predominantly vascular origin [4] .
Requirements for Brain Function
The energy demands of nervous tissue are very high and therefore sufficient blood supply to the brain must [5] comprises only 2% of total body mass, yet consumes at rest ~20% of the body's total basal oxygen supplied by 16% of the cardiac output. The brain's oxygen uptake is almost entirely for the oxidative metabolism of glucose, which in normal physiological conditions is the almost exclusive substrate for its energy requirements [6] .
The glucose metabolized in neurons is mainly to support cellular vegetative functions and the glucose consumption of neuronal cell bodies is essentially unaffected by functional activation, which is confined to synapse-rich regions, i.e. neuropil. The magnitudes of related increases in metabolism and blood-flow are linearly related to the frequency of action potentials in the afferent pathways regardless of whether they are excitatory or inhibitory.
Increased metabolism by functional activation is mainly used to restore the ionic gradients across the cell membrane degraded by the spike activity and is rather high compared to the demand of the cell body [7] . Overall, 87% of the energy consumed is required by action potential propagation and postsynaptic ion fl uxes, and only 13% is used for maintaining membrane resting potential [8] .
The consequence of CVD in tissue is ischemic cell death. This results from circulatory disturbances and an insufficient blood supply leading to a complex cascade of deleterious biochemical and molecular events, which in principle are amenable to therapeutic intervention [9, 10] .
Better understanding of these complex processes in ischemic stroke has improved treatment in the last decade.
Pathophysiological changes that lead to irreversible tissue damage must be targets for the development of is called the "ischemic penumbra" [11] , characterized by the potential for functional recovery without morphological damage, provided that local blood fl ow can be reestablished at a suffi cient level. Whereas neuronal function is impaired immediately when blood flow drops below the threshold, the development of irreversible morphological damage is time-dependent. The interaction between severity and duration of ischemia in the development of irreversible cell damage has been established in simultaneous recordings of cortical neuronal activity and local blood fl ow [12] . These results complement the concept of the ischemic penumbra:
the potential for post-ischemic recovery of functionally impaired cells is determined not only by the level of residual fl ow in the ischemic phase but also by the duration of the fl ow disturbance.
Autoradiographic procedures cannot demonstrate the gradual disappearance of the penumbra with increasing duration of ischemia, the progression of irreversible damage, or the recovery of functionally impaired tissue after reperfusion. To follow these pathophysiological changes, non-invasive imaging modalities, which permit repeated measurements of regional cerebral blood flow (rCBF) and regional cerebral blood volume (rCBV), as well as regional cerebral metabolic rate of oxygen (rCMRO 2 ) and of glucose (rCMRGlc), must be applied. To date, only positron emission tomography (PET) is able to quantify these variables repeatedly.
Early PET studies of stroke identified various tissue compartments within a cerebral region compromised by ischemia [13] [14] [15] [16] . Tissue with rCBF <12 mL/100 g/min or rCMRO 2 <65 μmol/100 g/min at the time of measurement (usually several hours after stroke) was found to be infarcted on late CTs. Relatively preserved CMRO 2 is an indicator of maintained neuronal integrity in regions with CBF reduced to 12-22 mL/100 g/min. This pattern, coined misery perfusion [14] , serves as a surrogate for the penumbra: it is the area with an increased oxygen extraction fraction (OEF) (to >80% from the normal value of ~40% in baboons and cats (reviewed in [17] [18] [19] (Fig. 1 ) [20, 21] imply that the extent of the penumbra, i.e. of morphologically intact but functionally impaired tissue, depends on the time of measurement relative to the onset of ischemia.
Flow measurements in the fi rst hours after a stroke allow the identification of various tissue compartments and their contribution to the fi nal infarct on CT/MRI. When the threshold for probable infarction was set to the conventional value of 12 mL/100 g/min and that for the upper limit of the penumbra to 18 mL/100 g/min, a large compartment of the final infarct (70%) was perfused at <12 mL/100 g/min, a level that predicts necrosis, while a smaller portion (18%)
had fl ow values in the penumbra range (12-18 mL/100 g/ min), and a fairly small compartment (12%) had perfusion at a higher level [20] . Only the tissue with CBF >12 mL/100 g/ min could benefi t from thrombolysis.
Non-invasive Imaging of the Penumbra
Measurement of rCBF, rCMRO 2 , and OEF by 15 indicates an intact cortex [17, 22] . With this tracer (Fig. 2) , the pathophysiological changes early after ischemic stroke can be accurately specifi ed: 55% of the volume of the fi nal infarct had decreased FMZ uptake, indicating infarction in the fi rst hours after stroke; and 21% of the fi nal infarct had fl ow <14 mL/100 g/min, but FMZ uptake above the critical value, indicating penumbra tissue [17] . However, selective neuronal loss can occur in tissue outside the documented penumbra or in re-perfused penumbra areas, and this can be documented by decreased cortical FMZ-binding [23] .
These results indicate the potential and the limits of therapy in acute stroke: early reperfusion cannot reverse the already-developed neuronal damage, but is crucial for salvaging the penumbra.
MR studies using diffusion and perfusion imaging might provide a differentiation between the core and the penumbra: the early diffusion-weighted imaging (DWI) lesion might defi ne the ischemic core and adjacent critically hypoperfused tissue might be identified with perfusionweighted imaging (PWI) [24] . Therefore, brain regions with hypoperfusion assessed by PWI but without restricted diffusion (PWI/DWI mismatch) have been assumed to represent the penumbra, but this surrogate definition has several uncertainties [25] . Several studies have been performed to validate this mismatch as a surrogate of the penumbra in the PET-derived discrimination of irreversibly damaged, critically perfused "at risk", and oligemic "not at risk" tissue. These studies demonstrated that DWI is a rather reliable predictor of the finally infarcted tissue [26] , but contains up to 25% false-positive, i.e. surviving tissue. The inaccuracy in defining the penumbra with the PWI/DWI mismatch is mainly related to the PWI, which uses variable parameters to estimate perfusion. As a consequence, the perfusion lesion size differs markedly depending on the parameters calculated [27] and is usually overestimated. Time-to-peak delays of 4 and 6 s reliably identify hypoperfused and exclude normoperfused tissue but overestimate the volume of critically perfused but salvageable tissue, i.e. the penumbra [28] . The mismatch volume in PWI/DWI as conventionally calculated therefore does not reliably refl ect misery perfusion, i.e. the penumbra as defined by PET (Fig. 3) . Several validation studies of various perfusion parameters calculated from PW-MRI on the fl ow values obtained from H 2 15 O-PET [29, 30] resulted in corrections permitting reliable classification of critical, but potentially reversible ischemia (T max , CBF, and timeto-peak). These thresholds have been implemented in recent clinical trials to improve the effi ciency of therapeutic interventions for stroke [31] . With the advances of arterial spin-labelling MR techniques [32] and CT perfusion studies for the determination of cerebral perfusion [33] , it will be necessary to validate the results of flow values from quantitative methods.
Detection of Hypoxic Tissue
Markers of hypoxia have been investigated with respect to their sensitivity in identifying penumbral tissue. Increased uptake of labeled nitroimidazole-derivatives is found in Wolf-Dieter Heiss. PET imaging in ischemic cerebrovascular disease: current status and future directions 717 the histologically-damaged ischemic core and in adjacent areas that are intact at follow up [34, 35] . The nitroimidazolederivative misonidazole labeled with 18 F-fl uoromisonidazole (FMISO), was fi rst used by Yeh et al. in 1994 [36] to investigate ischemic stroke in patients and revealed increased uptake surrounding a zone without FMISO uptake. The high uptake disappeared during the chronic phase, indicating that the FMISO-positive tissue had either infarcted or recovered.
These results were confirmed in a larger study by Read et al. in 1998 [37] : in 9 cases, FMISO-trapping was detected 6.25-42.5 h after stroke onset, but was absent in later examinations. Tissue with increased FMISO uptake was usually present in the periphery of the infarct identified on the co-registered late CT, but extended into normal tissue adjacent to the infarct in a few cases. The volume of tissue with increased FMISO uptake declined after stroke onset.
The proportions of hypoxic tissue that infarcted or survived varied between patients. Within 6 h of stroke onset, ~90%
of the FMISO-positive region was included in the fi nal infarct but this percentage was reduced later on [38] . In addition, the volume of initially affected tissue is correlated with the initial severity of neurologic defi cits, and the proportion of initially affected tissue progressing to infarction is correlated with neurological deterioration during the fi rst week after stroke [39] . 
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As high FMISO uptake in these areas fulfi lls the defi nition of the penumbra, the topography of FMISO-trapping can be used to generate a "penumbragram" [40] .
After 2-h transient occlusion of the MCA in the rat, the area of FMISO uptake is much larger than the area of subsequent infarctions, since a variable portion of the tissue detected by FMISO uptake does not go on to infarct if untreated [41] . However, in order to provide adequate time for the washout of unbound tracer, scanning of FMISO uptake cannot be performed until 2 h after injection. In addition, due to tracer dynamics, the timing of imaging is crucial with an optimal time of 2 h for the identifi cation of tissue at risk [42] . In permanent experimental MCA occlusion [43] and in human stroke [44] , a portion of the FMISO-trapping area may lie outside the final infarct and a portion of the final infarct may not exhibit early tracer mapping, indicating that FMISOtrapping does not accurately identify preventable infarction and therefore may not be specifi c to the penumbra. This may indicate that the hypoxia necessary for FMISO-binding is less severe than the oxygen depletion responsible for neuronal necrosis [18] . The required delay between tracer injection and imaging (>2 h) further limits the value of FMISO for the selection of effective treatment in acute ischemic stroke.
PET as a Surrogate Marker for Treatment Effi ciency
The efficacy of treatment in ischemic stroke can only be established by controlled, randomized, double-blind clinical trials, as successfully performed for thrombolysis with intravenous recombinant tissue plasminogen activator (rtPA) [45] . Such controlled trials require large groups of patients from many stroke centers, usually take a long time, and are expensive. Therefore surrogate markers may help to predict therapeutic effects in small groups of patients. Effects demonstrated with surrogate markers must be confi rmed in controlled trials with suffi cient patient populations. In recent years, identification of salvageable tissue by neuroimaging has attracted much interest as a surrogate marker for treatment effi ciency in stroke.
The effect of thrombolysis, the only approved treatment for acute ischemic stroke, has been shown in imaging studies, in which reperfusion to penumbral tissue is associated with improvement in neurological deficits (Fig. 4) : reperfusion significantly improves in rtPA-treated patients compared to controls [46] . The volume of tissue salvaged by reperfusion was determined by H 2 15 O-PET within 3 h of stroke onset and compared with the volume of infarction assessed on MRI 3 weeks after the stroke [47] . fl umazenil-binding is not reduced below a critical value [48] .
This marker identifies irreversibly damaged tissue that is not amenable to treatment.
In 34 patients with ischemic changes in >50% of the MCA territory in early cerebral CT scans, PET was performed with 11 C-FMZ to assess CBF and irreversible neuronal damage. Thereafter, probes for microdialysis and for measurement of intracranial pressure and tissue oxygen pressure were placed in the ipsilateral frontal lobe [53] . PET studies within 24 h after stroke identifi ed larger volumes of ischemic core and larger volumes of irreversible neuronal damage in patients with a subsequent malignant course (i.e., edema formation with midline shift) than in patients with a benign course (Fig. 5) . CBF within the ischemic core was significantly lower and the penumbra was smaller in the malignant than in the benign group. Therefore, PET may allow the prediction of malignant MCA infarction within the time window suggested for hemicraniectomy.
Neuromonitoring helps to classify the clinical courses by characterizing the pathophysiological sequelae of malignant edema formation. In contrast to PET, however, it does not predict a fatal outcome early enough for the successful implementation of invasive therapies.
Microglial Activation as an Indicator of Infl ammation
Microglia constitute up to 10% of the total cell population of the brain. As resident macrophages of the central nervous system (CNS), microglia phagocytose cellular debris, present foreign antigens, and are sensors of pathological events, including ischemia [54] . Microglia change from a resting to an activated state in response to CNS insults and function as phagocytes. In this activation process, they undergo a shift in their effector program by transforming their morphology, proliferating, releasing pro-inflammatory compounds, and increasing the expression of immunomodulatory surface antigens [55] .
As one consequence, the translocator protein 18 kDa (TSPO), formerly known as the peripheral benzodiazepine receptor (PBR), is upregulated in the mitochondria of activated microglia and may thus serve as a biomarker of inflammation. Several radioligands have been developed to image the activation of microglia in experimental models and in various diseases of the CNS [56] . Early studies in ischemia models using infl ammatory cells [57, 58] . In permanent ischemia induced by microspheres injection into the MCA of rats, no increase in 3 H-PK 11195-binding was found in the infarct core 7 days after the attack, but the permanent MCA ischemia caused increased tracer-binding in the normoperfused peri-infarct zone, which was co-localized with increased glucose metabolism and accumulated microglia and macrophages.
This peri-infarct neuroinflammation might contribute to the extension of tissue damage [59] . After temporary (45 min) MCA occlusion in hypertensive rats, significant increases in 11 C-PK 11195-binding in both the infarct and the surrounding areas were observed after 14 days, and less but still increased uptake was already present after 2 days [60] . With multimodal imaging including a tracer for mitochondrial complex I activity, neuronal damage is identifi able in the areas with neuroinfl ammation [61] .
Many histological studies have identified activated microglia in the ischemic brain after stroke in humans, especially in the ischemic core within 1 to 2 days after stroke. Over time, they extend from the ischemic core into the peri-infarct zones [55, 62] . In several studies, increased 11 C-PK11195 uptake has been observed around the ischemic lesions after several days, but also in regions distant from the lesion [56] . Increased PK-binding has also been documented in the ipsilateral thalamus and in the subcortical white matter. This relationship between neuroinflammation and the integrity of fiber tracts has been investigated more systematically by combining microglia PET with diffusion tensor imaging (DTI), which yields information about the anisotropic diffusion of water molecules along white-matter fiber tracts. Using DTI in a prospective controlled study, Radlinska et al. [63] demonstrated that microglial activation occurs along the pyramidal tract anterograde to the lesion only in those patients with acute subcortical stroke where the corticospinal tract is affected. These anterograde regions of the tract undergo Wallerian degeneration in the weeks and months after the stroke. This relationship was further investigated in a similarly-designed but longitudinal study [64] , in which the extent of anterograde microglial activity in the brainstem was found to be linearly related to the extent of pyramidal tract damage (Fig. 6 ). This remote 
Hemodynamic and Metabolic Reserve
Patients with arterial occlusive disease are protected against ischemic damage to a certain extent by compensatory mechanisms, which help to prevent critical ischemia when perfusion pressure drops. In patients with uni-or bilateral carotid artery disease, PET using 15 O-labelled tracers [66] indicates regional vasodilatation as a focal increase in cerebral blood volume (CBV) in the respective territory, and the ratio of CBF to CBV is used The lowest ratios are found in patients with symptoms indicating a hemodynamic rather than a thrombotic cause of the ischemia. At maximal vasodilatation, the perfusion reserve is exhausted and a further decrease in arterial pressure produces a proportional decrease in CBF and the CBF/CBV ratio. With this hemodynamic decompensation, the brain must draw upon the oxygen-carriage reserve to prevent energy failure and the OER is increased from the normal value of 40% to up to 85% [66] [67] [68] . Patients with submaximal elevations of OER represent 10% to 15% of the patients with cervical occlusive disease [66] ; their clinical symptoms are suggestive of hemodynamic ischemia.
On the basis of such PET measurements, it is therefore possible to discriminate patients with impaired hemodynamics only, as well as to quantify the impairment of perfusion reserve, using the CBF/CBV ratio. In addition, patients who are in a more precarious physiological state can be identified because (a) their hemodynamic reserve is exhausted and (b) their focal OER is increased.
These two homeostatic mechanisms seem to act in series, thereby preventing a fall in CMRO 2 and, hence, preventing functional disorder. Therefore, elevated OEF is an independent predictor for subsequent stroke in patients with symptomatic internal carotid artery disease, increasing the relative risk for ipsilateral stroke to ~7 [69] [70] [71] . The exhausted metabolic reserve can lead to selective neuronal loss in the cortex; this cannot be detected by morphological imaging (CT or MRI) but can be documented by FMZ-PET [72] . Removal of the arterial lesion by endarterectomy or stenting is successful in preventing further ischemic attacks; repeated multiparametric PET can reveal accompanying improvements in CBF, perfusion pressure, and oxygen metabolism [73] .
Deactivation of Remote Tissue (Diaschisis)
Even the earliest PET studies of ischemic brain lesions [74] revealed reduction of metabolism and blood fl ow exceeding the extent of morphologically damaged tissue (Fig. 7 ) -a regular finding since then with other functional imaging modalities as well, such as single-photon emission CT.
The most conspicuous effect is a reduction of CBF and metabolism in the contralateral cerebellum, called "crossed cerebellar diaschisis" (CCD) [75] , occurring immediately after a stroke and persisting permanently in patients suffering from lesions involving the cortico-ponto-cerebellar pathways, but it is reversed by successful reperfusion therapy [76] ( Fig. 7) . This CCD is clearly due to a neuronally-mediated functional effect, since a primary vascular cause can be excluded on account of the remote vascular territory. Further remote effects include reductions of CBF and metabolism in the ipsilateral cortex and basal ganglia.
Their cause is less clear, since selective ischemic neuronal loss or inadequate blood supply could also contribute in these areas. However, similar effects have also been observed in non-ischemic lesions such as brain tumors and intracerebral hematomas, so they seem therefore to be more closely related to the site than to the nature of the primary lesion [77] . Among cortical and subcortical lesions, infarcts of the parietal and frontal lobes most often cause signifi cant reductions of CBF and metabolism in the ipsilateral basal ganglia and the contralateral cerebellum.
Infarcts of the basal ganglia may induce ipsilateral cerebral as well as contralateral cerebellar deactivation. Thalamic infarcts have mainly diffuse ipsilateral cortical effects;
lesions of the medial thalamic nuclei apparently cause more widespread cortical metabolic reductions than those restricted to the anterior, ventrolateral, and posterior nuclei [78] . Infarcts of the brainstem and the cerebellum usually do not cause signifi cant asymmetric inactivations of forebrain structures.
It is important to note that diaschisis cannot be reliably detected by the usual PWI parameters [79] . Clinical symptoms not explained by the infarct proper can often be related to remote effects, and the severity of the metabolic changes appears to have an impact on functional recovery [80] . Especially in complex syndromes affecting parts of widespread functional networks, disturbance of a distinct function (e.g. language comprehension) is closely associated with the metabolic deactivation of a defined region (left temporo-parietal area) irrespective of infarct location [81] . Therefore, regional deactivation in specialized parts of a functional network plays a major role in the presentation of clinical syndromes and their resolution; re-organization of the affected network is of great importance for the recovery and rehabilitation of stroke victims. This complex topic is discussed in several reviews [82] [83] [84] [85] .
Vascular Dementia and Vascular Cognitive Impairment
Vascular cognitive disorders (VCDs) [86] include vascular cognitive impairment, vascular dementia (VaD, characterized by predominant deficits in executive functions and less prominent memory defects), and mixed Alzheimer VaD, and are responsible for cognitive deficits in 5% of people over the age of 65 years [87] . VCDs are heterogeneous diseases and may be caused by multiple neuropathological substrates [88, 89] . For the diagnosis of VaD and its differentiation from Alzheimer disease (AD), the presence of vascular risk factors and clinical features such as acute onset, stepwise progression, and emotional lability are used [90, 91] . In addition, neuroimaging can detect the location and extent of pathological changes related to disturbed brain function [92] .
Overall, PET studies in patients with VaD demonstrate reduced CBF and CMRO 2 , but normal OEF due to chronic ischemia [93] . In patients with large infarcts, leukoaraiosis and deep white-matter abnormalities, decreased CBF and CMRO 2 in the overlying grey matter are associated with the severity of cognitive impairment [94] .
In VaD, fludeoxyglucose (FDG) PET shows focal cortical and subcortical hypometabolism, a pattern different from the changes in metabolism in AD (Fig. 8) affecting the association areas [95] . However, various patterns of disturbance of CBF and metabolism are observed in different conditions of vascular pathology (details in review [92] ).
Post-stroke dementia (PSD) is a special case with cognitive impairment developing after the stroke, irrespective of signs of pre-existing cognitive decline. The prevalence of PSD is ~30%, i.e. 3.5 to 5.8 times greater than age-matched controls [96] . The high rate of cognitive impairment after a stroke could be caused by vascular risk factors and AD-typical metabolic changes. Clinical and experimental studies (summarized in [97] ) indicate a link between vascular risk factors and degenerative dementia which is mediated by inflammation. In animal models, microglial activation after ischemia is exacerbated in the presence of amyloid and infarcts over time [98] . The processes responsible for the development of PSD can be investigated by multi-tracer PET and may serve as a basis for the development of preventive therapy.
Complex Activation Studies
Regional cerebral metabolism and blood flow are dependent on the functional state of the brain tissue. This has been well established in animal experiments using autoradiography [99] . A direct coupling of neuronal activity and focal blood flow has been demonstrated directly by simultaneous recordings with microelectrodes [100] . The transfer to human studies was achieved by the 133 Xenon clearance method for the measurement of regional cerebral blood fl ow [101] , by which two-dimensional cortical activation patterns for various tasks including speech and memory were obtained. With the advance of PET, three-dimensional regional activation studies became feasible in healthy controls and in patients with various CNS disorders [102] . Due to the radiation exposure and the complex logistics required by PET, these activation studies were taken over by fMRI with the availability of high-resolution MR equipment [103] .
However, PET activation studies are still required and justified for the detection of changes in the complex patterns elicited by stimulation procedures not feasible in MRI.
Our group has long experience with activation studies in aphasia [84] . In the brain of right-handers and many lefthanders, language is a function of the left, dominant
hemisphere. This asymmetry is established during maturation and maintained by fi ber bundles connecting both hemispheres across the corpus callosum. These fi bers are glutaminergic and are connected to inhibitory interneurons in the non-dominant hemisphere. This means that language areas active in Broca's area suppress homologous areas in the non-dominant hemisphere (transcallosal inhibition).
The existence of these inhibitory mechanisms has been deduced from imaging studies in patients with brain lesions and has been demonstrated directly in normal subjects using imaging-guided repetitive transcranial magnetic stimulation (rTMS) (Fig. 9 ) [104] . A lesion in the language areas of the dominant hemisphere not only reduces activity in the affected hemisphere, but also activates areas in the unaffected hemisphere by interrupting transcallosal inhibitory fibers [105] . This activity of regions in areas of the non-dominant hemisphere after a stroke has been repeatedly detected in imaging studies [106] . In the following weeks and months, activation shifts back to the dominant hemisphere. This backward shift varies considerably and might be responsible for the successful recovery of language function [107] . For successful rehabilitation, the reactivation of networks in the dominant hemisphere seems to be a more effi cient strategy than recruiting homologous brain regions in the unaffected non-dominant hemisphere.
Right-hemispheric regions can be compensatory in chronic aphasics [108] , but this seems to be a less effective long-term strategy if left-hemisphere areas can no longer be recruited.
Based on these data, a strategy for the rehabilitation of language function should suppress the right hemisphere and enhance left-hemisphere activity after stroke. Results from a study in post-stroke aphasia show that activity of the non-lesioned hemisphere can be decreased by inhibitory rTMS. The induced shift of activation to the dominant hemisphere is associated with an improvement in language function. Speech therapy combined with inhibitory rTMS of the area in the non-dominant hemisphere homologous to Broca's area might be a successful treatment for poststroke aphasia [109] .
Future Perspectives: Multimodal Imaging
With technical developments for the integration of different modalities, e.g. MRI and PET, the investigation of various already has widespread applications in experimental research [111] and promising potential in humans [112] [113] [114] . The co-registration of various parameters also improves the quality of results: MR data are used for the correction of partial volume effects in small structures and dynamic information from MRI can be used for the quantifi cation of parametric values by PET (Fig. 10) .
Simultaneous multifunctional and multiparametric imaging might have a signifi cant impact in stroke research:
it guarantees exactly the same physiological state for comparative measurements of perfusion by PET and MRI; it permits differentiation of core and penumbra, demonstrates time-dependent growth of infarction, and may be used to determine the optimal therapy for a certain time after the stroke; the vascular origin of the stroke can be detected by magnetic resonance angiography, and by FDG yields precise information about glycolysis. Other molecules important in glucose metabolism, such as lactate and pyruvate, can be detected by 13 C-MRS, which could be used together with FDG-PET to monitor different aspects of glucose metabolism in various diseases [116] . dynamic contrast-enhanced MR might become feasible and yield information on revascularization processes in the course after stroke [117] . Monitoring the location and following the migration of grafted stem or progenitor cells will be essential in the development of cell replacement strategies for the treatment of various neurological disorders. The cells can be labelled with iron oxide particles and their survival and migration to the ischemic lesion can be followed by MRI [118] . Combining MRI for tracking cells with PET for detecting their biological activity could demonstrate the viability of the cells as well as their integration into functional networks [119, 120] .
Conclusion
Over 
